nodes	percent_of_prediction	percent_of_DWPC	metapath
Lincomycin—Abdominal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00532	0.00532	CcSEcCtD
Lincomycin—Abdominal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00532	0.00532	CcSEcCtD
Lincomycin—Pancytopenia—Topotecan—peripheral nervous system neoplasm	0.00531	0.00531	CcSEcCtD
Lincomycin—Local reaction—Epirubicin—peripheral nervous system neoplasm	0.0053	0.0053	CcSEcCtD
Lincomycin—Vesiculobullous rash—Epirubicin—peripheral nervous system neoplasm	0.00523	0.00523	CcSEcCtD
Lincomycin—Neutropenia—Topotecan—peripheral nervous system neoplasm	0.00523	0.00523	CcSEcCtD
Lincomycin—Pancytopenia—Melphalan—peripheral nervous system neoplasm	0.0052	0.0052	CcSEcCtD
Lincomycin—Neutropenia—Tretinoin—peripheral nervous system neoplasm	0.00519	0.00519	CcSEcCtD
Lincomycin—Neutropenia—Isotretinoin—peripheral nervous system neoplasm	0.00519	0.00519	CcSEcCtD
Lincomycin—Neutropenia—Melphalan—peripheral nervous system neoplasm	0.00512	0.00512	CcSEcCtD
Lincomycin—Dermatitis bullous—Alitretinoin—peripheral nervous system neoplasm	0.00509	0.00509	CcSEcCtD
Lincomycin—Anorectal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00496	0.00496	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Tretinoin—peripheral nervous system neoplasm	0.00491	0.00491	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Isotretinoin—peripheral nervous system neoplasm	0.00491	0.00491	CcSEcCtD
Lincomycin—Local reaction—Doxorubicin—peripheral nervous system neoplasm	0.0049	0.0049	CcSEcCtD
Lincomycin—Stomatitis—Topotecan—peripheral nervous system neoplasm	0.00486	0.00486	CcSEcCtD
Lincomycin—Liver function test abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00485	0.00485	CcSEcCtD
Lincomycin—Vesiculobullous rash—Doxorubicin—peripheral nervous system neoplasm	0.00484	0.00484	CcSEcCtD
Lincomycin—Stomatitis—Tretinoin—peripheral nervous system neoplasm	0.00482	0.00482	CcSEcCtD
Lincomycin—Stomatitis—Isotretinoin—peripheral nervous system neoplasm	0.00482	0.00482	CcSEcCtD
Lincomycin—Phlebitis—Cisplatin—peripheral nervous system neoplasm	0.00481	0.00481	CcSEcCtD
Lincomycin—Oesophagitis—Etoposide—peripheral nervous system neoplasm	0.00478	0.00478	CcSEcCtD
Lincomycin—Stomatitis—Melphalan—peripheral nervous system neoplasm	0.00476	0.00476	CcSEcCtD
Lincomycin—Jaundice—Melphalan—peripheral nervous system neoplasm	0.00476	0.00476	CcSEcCtD
Lincomycin—Agranulocytosis—Tretinoin—peripheral nervous system neoplasm	0.00462	0.00462	CcSEcCtD
Lincomycin—Agranulocytosis—Isotretinoin—peripheral nervous system neoplasm	0.00462	0.00462	CcSEcCtD
Lincomycin—Phlebitis—Etoposide—peripheral nervous system neoplasm	0.00441	0.00441	CcSEcCtD
Lincomycin—Pancytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00431	0.00431	CcSEcCtD
Lincomycin—Neutropenia—Dactinomycin—peripheral nervous system neoplasm	0.00424	0.00424	CcSEcCtD
Lincomycin—Erythema multiforme—Isotretinoin—peripheral nervous system neoplasm	0.0042	0.0042	CcSEcCtD
Lincomycin—Erythema multiforme—Tretinoin—peripheral nervous system neoplasm	0.0042	0.0042	CcSEcCtD
Lincomycin—Tinnitus—Isotretinoin—peripheral nervous system neoplasm	0.00414	0.00414	CcSEcCtD
Lincomycin—Tinnitus—Tretinoin—peripheral nervous system neoplasm	0.00414	0.00414	CcSEcCtD
Lincomycin—Abdominal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00403	0.00403	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Dactinomycin—peripheral nervous system neoplasm	0.00401	0.00401	CcSEcCtD
Lincomycin—Stomatitis—Dactinomycin—peripheral nervous system neoplasm	0.00394	0.00394	CcSEcCtD
Lincomycin—Neutropenia—Alitretinoin—peripheral nervous system neoplasm	0.00393	0.00393	CcSEcCtD
Lincomycin—Pancytopenia—Vincristine—peripheral nervous system neoplasm	0.00385	0.00385	CcSEcCtD
Lincomycin—Neutropenia—Vincristine—peripheral nervous system neoplasm	0.00379	0.00379	CcSEcCtD
Lincomycin—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.00377	0.00377	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Alitretinoin—peripheral nervous system neoplasm	0.00372	0.00372	CcSEcCtD
Lincomycin—Abscess—Epirubicin—peripheral nervous system neoplasm	0.00371	0.00371	CcSEcCtD
Lincomycin—Rash pustular—Epirubicin—peripheral nervous system neoplasm	0.00368	0.00368	CcSEcCtD
Lincomycin—Stomatitis—Alitretinoin—peripheral nervous system neoplasm	0.00366	0.00366	CcSEcCtD
Lincomycin—Angioedema—Topotecan—peripheral nervous system neoplasm	0.00356	0.00356	CcSEcCtD
Lincomycin—Stomatitis—Vincristine—peripheral nervous system neoplasm	0.00352	0.00352	CcSEcCtD
Lincomycin—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.0035	0.0035	CcSEcCtD
Lincomycin—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00349	0.00349	CcSEcCtD
Lincomycin—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00344	0.00344	CcSEcCtD
Lincomycin—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.00343	0.00343	CcSEcCtD
Lincomycin—Abscess—Doxorubicin—peripheral nervous system neoplasm	0.00343	0.00343	CcSEcCtD
Lincomycin—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00342	0.00342	CcSEcCtD
Lincomycin—Pancytopenia—Cisplatin—peripheral nervous system neoplasm	0.0034	0.0034	CcSEcCtD
Lincomycin—Rash pustular—Doxorubicin—peripheral nervous system neoplasm	0.0034	0.0034	CcSEcCtD
Lincomycin—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Lincomycin—Oliguria—Epirubicin—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Lincomycin—Glossitis—Epirubicin—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Lincomycin—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Lincomycin—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00316	0.00316	CcSEcCtD
Lincomycin—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00316	0.00316	CcSEcCtD
Lincomycin—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Lincomycin—Pancytopenia—Etoposide—peripheral nervous system neoplasm	0.00312	0.00312	CcSEcCtD
Lincomycin—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00312	0.00312	CcSEcCtD
Lincomycin—Stomatitis—Cisplatin—peripheral nervous system neoplasm	0.00311	0.00311	CcSEcCtD
Lincomycin—Shock—Tretinoin—peripheral nervous system neoplasm	0.0031	0.0031	CcSEcCtD
Lincomycin—Shock—Isotretinoin—peripheral nervous system neoplasm	0.0031	0.0031	CcSEcCtD
Lincomycin—Neutropenia—Etoposide—peripheral nervous system neoplasm	0.00307	0.00307	CcSEcCtD
Lincomycin—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Lincomycin—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Lincomycin—Oliguria—Doxorubicin—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Lincomycin—Glossitis—Doxorubicin—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Lincomycin—Vaginal inflammation—Epirubicin—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Lincomycin—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00291	0.00291	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.0029	0.0029	CcSEcCtD
Lincomycin—Stomatitis—Etoposide—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Lincomycin—Jaundice—Etoposide—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Lincomycin—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00283	0.00283	CcSEcCtD
Lincomycin—Colitis—Epirubicin—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Lincomycin—Vaginal infection—Epirubicin—peripheral nervous system neoplasm	0.00277	0.00277	CcSEcCtD
Lincomycin—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Lincomycin—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Lincomycin—Pain—Topotecan—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Lincomycin—Vaginal inflammation—Doxorubicin—peripheral nervous system neoplasm	0.00271	0.00271	CcSEcCtD
Lincomycin—Pain—Isotretinoin—peripheral nervous system neoplasm	0.0027	0.0027	CcSEcCtD
Lincomycin—Pain—Tretinoin—peripheral nervous system neoplasm	0.0027	0.0027	CcSEcCtD
Lincomycin—Oesophagitis—Epirubicin—peripheral nervous system neoplasm	0.00268	0.00268	CcSEcCtD
Lincomycin—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00267	0.00267	CcSEcCtD
Lincomycin—Pain—Melphalan—peripheral nervous system neoplasm	0.00266	0.00266	CcSEcCtD
Lincomycin—Colitis—Doxorubicin—peripheral nervous system neoplasm	0.00261	0.00261	CcSEcCtD
Lincomycin—Vaginal infection—Doxorubicin—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Lincomycin—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00255	0.00255	CcSEcCtD
Lincomycin—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00254	0.00254	CcSEcCtD
Lincomycin—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Lincomycin—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Lincomycin—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Lincomycin—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Lincomycin—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Lincomycin—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Lincomycin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00249	0.00249	CcSEcCtD
Lincomycin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00249	0.00249	CcSEcCtD
Lincomycin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00249	0.00249	CcSEcCtD
Lincomycin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00249	0.00249	CcSEcCtD
Lincomycin—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Lincomycin—Oesophagitis—Doxorubicin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Lincomycin—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Lincomycin—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Lincomycin—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Lincomycin—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Lincomycin—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Lincomycin—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Lincomycin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Lincomycin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Lincomycin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Lincomycin—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Lincomycin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Lincomycin—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Lincomycin—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Lincomycin—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Lincomycin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Lincomycin—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Lincomycin—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Lincomycin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Lincomycin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Lincomycin—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Lincomycin—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Lincomycin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.0022	0.0022	CcSEcCtD
Lincomycin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Lincomycin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Lincomycin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Lincomycin—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Lincomycin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Lincomycin—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Lincomycin—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Lincomycin—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Lincomycin—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Lincomycin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Lincomycin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Lincomycin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Lincomycin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Lincomycin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Lincomycin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Lincomycin—Rash—Topotecan—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Lincomycin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Lincomycin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Lincomycin—Rash—Tretinoin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Lincomycin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Lincomycin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Lincomycin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Lincomycin—Pain—Vincristine—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Lincomycin—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Lincomycin—Rash—Melphalan—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Lincomycin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Lincomycin—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Lincomycin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Lincomycin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Lincomycin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Lincomycin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Lincomycin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Lincomycin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Lincomycin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Lincomycin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Lincomycin—Nausea—Melphalan—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Lincomycin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Lincomycin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Lincomycin—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Lincomycin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Lincomycin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Lincomycin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Lincomycin—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Lincomycin—Pain—Cisplatin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Lincomycin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Lincomycin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Lincomycin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Lincomycin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Lincomycin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Lincomycin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Lincomycin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Lincomycin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Lincomycin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Lincomycin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Lincomycin—Pain—Etoposide—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Lincomycin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Lincomycin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Lincomycin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Lincomycin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Lincomycin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Lincomycin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Lincomycin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Lincomycin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Lincomycin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Lincomycin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Lincomycin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Lincomycin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Lincomycin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Lincomycin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Lincomycin—Rash—Vincristine—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Lincomycin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Lincomycin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Lincomycin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Lincomycin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Lincomycin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Lincomycin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Lincomycin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Lincomycin—Nausea—Vincristine—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Lincomycin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Lincomycin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Lincomycin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Lincomycin—Rash—Cisplatin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Lincomycin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Lincomycin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Lincomycin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Lincomycin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Lincomycin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Lincomycin—Rash—Etoposide—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Lincomycin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Lincomycin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Lincomycin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Lincomycin—Nausea—Etoposide—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Lincomycin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Lincomycin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Lincomycin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Lincomycin—Shock—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Lincomycin—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000978	0.000978	CcSEcCtD
Lincomycin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000968	0.000968	CcSEcCtD
Lincomycin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000953	0.000953	CcSEcCtD
Lincomycin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000905	0.000905	CcSEcCtD
Lincomycin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000895	0.000895	CcSEcCtD
Lincomycin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000831	0.000831	CcSEcCtD
Lincomycin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000828	0.000828	CcSEcCtD
Lincomycin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000827	0.000827	CcSEcCtD
Lincomycin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000827	0.000827	CcSEcCtD
Lincomycin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000771	0.000771	CcSEcCtD
Lincomycin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000769	0.000769	CcSEcCtD
Lincomycin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000765	0.000765	CcSEcCtD
Lincomycin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000765	0.000765	CcSEcCtD
Lincomycin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00074	0.00074	CcSEcCtD
Lincomycin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000716	0.000716	CcSEcCtD
Lincomycin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000713	0.000713	CcSEcCtD
Lincomycin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000685	0.000685	CcSEcCtD
Lincomycin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000665	0.000665	CcSEcCtD
Lincomycin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000663	0.000663	CcSEcCtD
Lincomycin—Rash—Epirubicin—peripheral nervous system neoplasm	0.00066	0.00066	CcSEcCtD
Lincomycin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000659	0.000659	CcSEcCtD
Lincomycin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000622	0.000622	CcSEcCtD
Lincomycin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000616	0.000616	CcSEcCtD
Lincomycin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000611	0.000611	CcSEcCtD
Lincomycin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00061	0.00061	CcSEcCtD
Lincomycin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
